Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on "Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study"
- PMID: 38973180
- PMCID: PMC11540389
- DOI: 10.3350/cmh.2024.0519
Nucleos(t)ide analog therapy of chronic hepatitis B and extrahepatic cancer risk: Is tenofovir better than entecavir?: Editorial on "Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study"
Keywords: Antiviral drug; Chronic hepatitis B; Tumor.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Comment on
-
Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study.Clin Mol Hepatol. 2024 Jul;30(3):500-514. doi: 10.3350/cmh.2024.0055. Epub 2024 May 10. Clin Mol Hepatol. 2024. PMID: 38726505 Free PMC article.
Similar articles
-
Efficacy and safety of tenofovir in a kidney transplant patient with chronic hepatitis B and nucleos(t)ide multidrug resistance: a case report.J Med Case Rep. 2014 Aug 21;8:281. doi: 10.1186/1752-1947-8-281. J Med Case Rep. 2014. PMID: 25146249 Free PMC article.
-
Comparison of first-year results of tenofovir and entecavir treatments of nucleos(t)ide-naive chronic hepatitis B patients with hepatosteatosis.Saudi J Gastroenterol. 2015 Nov-Dec;21(6):396-9. doi: 10.4103/1319-3767.164186. Saudi J Gastroenterol. 2015. PMID: 26655136 Free PMC article.
-
Comparative efficacy of tenofovir and entecavir in nucleos(t)ide analogue-naive chronic hepatitis B: A systematic review and meta-analysis.PLoS One. 2019 Nov 21;14(11):e0224773. doi: 10.1371/journal.pone.0224773. eCollection 2019. PLoS One. 2019. PMID: 31751366 Free PMC article.
-
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B.Liver Int. 2020 Jul;40(7):1578-1589. doi: 10.1111/liv.14482. Epub 2020 Apr 30. Liver Int. 2020. PMID: 32304611
-
Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?Clin Liver Dis. 2023 Nov;27(4):809-818. doi: 10.1016/j.cld.2023.05.005. Epub 2023 Jun 30. Clin Liver Dis. 2023. PMID: 37778771 Review.
References
-
- Polaris Observatory Collaborators Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383–403. - PubMed
-
- Tang LSY, Covert E, Wilson E, Kottilil S. Chronic hepatitis B infection: A review. JAMA. 2018;319:1802–1813. - PubMed
-
- Lok AS, McMahon BJ, Brown RS, Jr, Wong JB, Ahmed AT, Farah W, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis. Hepatology. 2016;63:284–306. - PubMed
Publication types
LinkOut - more resources
Full Text Sources